Skip to main content
. 2010 Apr 27;340:c1804. doi: 10.1136/bmj.c1804

Table 1.

  Number of women and woman years at risk with percentage distribution in cervical screening programme

HPV screening Conventional screening
Women Woman years % of women years Women years per woman Women Woman years % of women years Women years per woman
Invitees 29 037 95 553 100.0 3.3 29 039 95 666 100.0 3.3
Attendees 19 449 64 025 67.0 3.3 19 221 63 396 66.3 3.3
Non-attendees 9588 31 528 33.0 3.3 9818 32 270 33.7 3.3
Screening group (among attendees):
 Screening test positive 1354 4544 7.1 3.4 1125 3766 5.9 3.3
  Screening episode positive 110 370 0.6 3.4 72 235 0.4 3.3
  Recommendation for intensified screening* 1244† 4174 6.5 3.4 1053 3531 5.6 3.4
 Screening test negative 18 095 59 480 92.9 3.3 18 096 59 630 94.1 3.3
By age group (years):
 Age 30-39:
  Invitees 7939 25 961 100.0 3.3 7894 25 852 100.0 3.3
  Attendees 4630 15 152 58.4 3.3 4571 15 000 58.0 3.3
 Age 40-49:
  Invitees 8893 29 337 100.0 3.3 8849 29 292 100.0 3.3
  Attendees 5894 19 485 66.4 3.3 5728 18 951 64.7 3.3
 Age 50-64:
  Invitees 12 205 40 257 100.0 3.3 12 296 40 522 100.0 3.3
  Attendees 8925 29 389 73.0 3.3 8922 29 445 72.7 3.3

*In women recommended for intensified screening, four in HPV group and 29 in conventional group had inadequate screening test.

†Out of 1244 women who were recommended for intensified screening in HPV screening arm, HPV test was done and was positive for 1151 women: 353 of them were Papanicolaou class II+ at cytology triage, 794 were class I, and 4 had inadequate smear. HPV test was not done for 93 women, and recommendation was based on Papanicolaou class II+ result among them.